Citations to this article

Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
O M El-Badry, … , M M Rechler, M A Israel
O M El-Badry, … , M M Rechler, M A Israel
Published September 1, 1989
Citation Information: J Clin Invest. 1989;84(3):829-839. https://doi.org/10.1172/JCI114243.
View: Text | PDF
Research Article

Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.

Abstract

Insulin-like growth factor II (IGF-II) mRNA was increased in two of eight neuroblastomas and in eight of eight pheochromocytomas, tumors of the adrenal medulla that occur in childhood and adulthood, respectively. RNA encoding the type I IGF receptor, the receptor thought to mediate the mitogenic effects of IGF-I and IGF-II, also was uniformly expressed in these cells. To assess the role of IGF-II in the growth of these tumor cells, we have used the SK-N-AS cultured neuroblastoma cell line, which can be continuously propagated in mitogen-free medium, as a model system. Our results strongly suggest that IGF-II, synthesized by SK-N-AS cells and acting through type I IGF receptors, contributes to the autonomous growth of this tumor cell line. (a) SK-N-AS cells synthesized large amounts of IGF-II RNA and secreted greater than 50 ng/ml of IGF-II (as determined by specific radioimmuno- and radioreceptor assays). Little, if any, IGF-I RNA or immunoreactive IGF-I were detected. (b) SK-N-AS cells possess type I IGF receptors. (c) Exogenous IGF-I and IGF-II stimulated DNA synthesis in SK-N-AS cells, and this stimulation was abolished by a blocking antibody to the type I IGF receptor. (d) This anti-receptor antibody also abolished the multiplication of SK-N-AS cells in the absence of added mitogens. We conclude that IGF-II is an autocrine growth factor for SK-N-AS cells and suggest that this mechanism may contribute to the growth of some adrenal medullary tumors.

Authors

O M El-Badry, J A Romanus, L J Helman, M J Cooper, M M Rechler, M A Israel

×

Total citations by year

Year: 2024 2020 2018 2017 2015 2014 2013 2012 2011 2010 2009 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Total
Citations: 1 3 1 1 2 3 2 2 4 4 2 2 1 3 3 3 4 2 5 3 4 11 2 6 10 16 16 14 4 134
Citation information

Citations to this article (134)

Title and authors Publication Year
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma
Stauffer S, Roth JS, Hernandez ER, Kowalczyk JT, Sealover NE, Hebron KE, James A, Isanogle KA, Riffle LA, Ileva L, Luo X, Chen JQ, Kedei N, Kortum RL, Lei H, Shern JF, Kalen JD, Edmondson EF, Hall MD, Difilippantonio S, Thiele CJ, Yohe ME 		Cancers 2024
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression
TT Tomić, J Olausson, A Rehammar, L Deland, A Muth, K Ejeskär, S Nilsson, E Kristiansson, ON Wassén, F Abel, MD Wilkerson 		PLoS genetics 2020
Mechanisms of Efficacy of the FGFR1–3 Inhibitor AZD4547 in Pediatric Solid Tumor Models
N Phanhthilath, S Hakim, C Su, A Liu, D Subramonian, J Lesperance, PE Zage 		Investigational New Drugs 2020
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner
J Mazar, C Gordon, V Naga, TJ Westmoreland 		Anti-cancer agents in medicinal chemistry 2020
miR-483-3p promotes proliferation and migration of neuroblastoma cells by targeting PUMA
Kai Wu, Jianjun Wang, Jixian He, Qinming Chen, Liucheng Yang 		International journal of clinical and experimental pathology 2018
Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis
C Zeng, X Feng, W Wang, L Lv, C Fang, L Chi, L Huang, Z Zhou 		Oncology Letters 2017
High IGF2 expression is associated with poor clinical outcome in human ovarian cancer
Y Dong, J Li, F Han, H Chen, X Zhao, Q Qin, R Shi, J Liu 		Oncology reports 2015
IGF2BP1 Harbors Prognostic Significance by Gene Gain and Diverse Expression in Neuroblastoma
JL Bell, R Turlapati, T Liu, JH Schulte, S Hüttelmaier 		Journal of Clinical Oncology 2015
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
M Fouladi, JP Perentesis, LM Wagner, AA Vinks, JM Reid, C Ahern, G Thomas, CA Mercer, DA Krueger, PJ Houghton, LA Doyle, H Chen, B Weigel, SM Blaney 		Clinical cancer research 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick 		Comprehensive Physiology 2014
IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
M Guillaud-Bataille, B Ragazzon, A Reyniès, C Chevalier, I Francillard, O Barreau, V Steunou, J Guillemot, F Tissier, M Rizk-Rabin, F René-Corail, AA Ghuzlan, G Assié, X Bertagna, E Baudin, YL Bouc, J Bertherat, E Clauser, IV Lebedeva 		PloS one 2014
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group: Phase 2 Study of Cixutumumab
B Weigel, S Malempati, JM Reid, SD Voss, SY Cho, HX Chen, M Krailo, D Villaluna, PC Adamson, SM Blaney 		Pediatric Blood & Cancer 2013
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
MJ Wagner, RG Maki 		Frontiers in Oncology 2013
Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
S Malempati, B Weigel, AM Ingle, CH Ahern, JM Carroll, CT Roberts, JM Reid, S Schmechel, SD Voss, SY Cho, HX Chen, MD Krailo, PC Adamson, SM Blaney 		Journal of Clinical Oncology 2012
UPR-Induced Resistance to Etoposide Is Downstream of PERK and Independent of Changes in Topoisomerase IIα Levels
MJ Mann, ER Pereira, N Liao, LM Hendershot, DY Jin 		PloS one 2012
Enhanced efficacy of IGF1R inhibition in paediatric glioblastoma by combinatorial targeting of PDGFRα/β
A Bielen, L Perryman, GM Box, M Valenti, AH Brandon, V Martins, A Jury, S Popov, S Gowan, S Jeay, FI Raynaud, F Hofmann, D Hargrave, SA Eccles, C Jones 		Molecular cancer therapeutics 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken 		Advances in Cancer Research Volume 110 2011
Neuroblastoma therapy: what is in the pipeline?
CS Verissimo, JJ Molenaar, CP Fitzsimons, E Vreugdenhil 		Endocrine Related Cancer 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program
EA Kolb, R Gorlick, JM Maris, ST Keir, CL Morton, J Wu, AW Wozniak, MA Smith, PJ Houghton 		Pediatric Blood & Cancer 2011
Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2)
J Li, I Neumann, I Volkmer, MS Staege 		Molecular Biology Reports 2010
Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma
B Geoerger, JF Brasme, E Daudigeos-Dubus, P Opolon, C Venot, L Debussche, P Vrignaud, G Vassal 		European Journal of Cancer 2010
Insulin-like growth factor-1 and childhood cancer risk
M Badr, T Hassan, SE Tarhony, W Metwally 		Oncology Letters 2010
Pharmacotherapy of neuroblastoma
RE George, L Diller, ML Bernstein 		Expert Opinion on Pharmacotherapy 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd 		Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
The Role of IGF‐1R in Pediatric Malignancies
SY Kim, JA Toretsky, D Scher, LJ Helman 		The oncologist 2009
Effects of plasminogen, streptokinase, and their equimolar complexes with pyruvate kinase on the human neuroblastoma IMR-32 cells
AA Romanovskaya, VN Nikandrov 		Cell and Tissue Biology 2007
IGF signaling as a therapeutic target in pediatric solid tumors of the central and peripheral nervous system
MA Grotzer, AS Guerreiro, JP Bourquin, A Arcaro 		Expert Review of Endocrinology & Metabolism 2007
Role of DHEA and Growth Factors in Chromaffin Cell Proliferation
F Sicard, A Krug, C Ziegler, S Sperber, M Ehrhart-Bornstein, S Bornstein 		Annals of the New York Academy of Sciences 2006
The Somatotrophic Axis in Brain Function
HJ Schneider, GK Stalla 		The Somatotrophic Axis in Brain Function 2005
Handbook of the Biology of Aging
PM Wise 		Handbook of the Biology of Aging 2005
Farnesyltransferaseinhibitoren: Hoffnungsvoller neuer Ansatz in der Therapie des Neuroblastoms?
R Girgert 		Monatsschrift Kinderheilkunde 2005
Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells
B Tanno, V Cesi, R Vitali, F Sesti, ML Giuffrida, C Mancini, B Calabretta, G Raschellà 		Cell Death and Differentiation 2004
Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines
F Navid, BT Mischen, LJ Helman 		Sarcoma 2004
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms
G Pozzi, M Guidi, F Laudicina, M Marazzi, L Falcone, R Betti, C Crosti, EE Müller, GE DiMattia, V Locatelli, A Torsello 		Journal of Endocrinological Investigation 2004
Prenatal exposure of rats to Ginkgo biloba extract (EGb 761) increases neuronal survival/growth and alters gene expression in the developing fetal hippocampus
W Li, F Trovero, J Cordier, Y Wang, K Drieu, V Papadopoulos 		Developmental Brain Research 2003
Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma
F Hedborg, E Ullerås, L Grimelius, E Wassberg, PH Maxwell, B Hero, F Berthold, F Schilling, D Harms, B Sandstedt, G Franklin 		The FASEB Journal 2003
Farnesyltransferase inhibitor FTI-277 prevents autocrine growth stimulation of neuroblastoma by BDNF
R Girgert, J Wittrock, S Pfister, P Schweizer 		Journal of Cancer Research and Clinical Oncology 2003
A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan
CS Carter, MM Ramsey, WE Sonntag 		Trends in Genetics 2002
Models of Growth Hormone and IGF-1 Deficiency: Applications to Studies of Aging Processes and Life-Span Determination
CS Carter, MM Ramsey, RL Ingram, AB Cashion, WT Cefalu, ZQ Wang, WE Sonntag 		The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002
Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development
D Seurin, C Lassarre, G Bienvenu, S Babajko 		European Journal of Cancer 2002
Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms
B Tanno, A Negroni, R Vitali, MC Pirozzoli, V Cesi, C Mancini, B Calabretta, G Raschellà 		The Journal of biological chemistry 2002
Hepatitis C Virus Core Protein Transactivates Insulin-like Growth Factor II Gene Transcription through Acting Concurrently on Egr1 and Sp1 Sites
S Lee, U Park, YI Lee 		Virology 2001
IGFBPs are involved in xenograft development in nude mice
S Babajko, P Grellier, B Gall, M Menouny, M Binoux 		Medical and Pediatric Oncology 2001
Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein
F Navid, JJ Letterio, CL Yeung, M Pegtel, LJ Helman 		Sarcoma 2000
The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing
WE Sonntag, C Lynch, P Thornton, A Khan, S Bennett, R Ingram 		Journal of Anatomy 2000
Regulation of the Insulin-Like Growth Factor-I Receptor Gene by Oncogenes and Antioncogenes: Implications in Human Cancer
H Werner, M Shalita-Chesner, S Abramovitch, G Idelman, L Shaharabani-Gargir, T Glaser 		Molecular Genetics and Metabolism 2000
The role of the insulin-like growth factor system in adrenocortical tumourigenesis
MM Weber, C Fottner, E Wolf 		European Journal of Clinical Investigation 2000
Multi-hormonal regulation of IGFBP-6 expression in human neuroblastoma cells
D Chambery, BD Galle, E Ehrenborg, S Babajko 		Growth Hormone & IGF Research 2000
Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells
CJ Kim, T Matsuo, KH Lee, CJ Thiele 		The American Journal of Pathology 1999
Transforming growth factor-β, but not ciliary neurotrophic factor, inhibits DNA synthesis of adrenal medullary cells in vitro
N Wolf, K Krohn, S Bieger, M Frödin, S Gammeltoft, K Krieglstein, K Unsicker 		Neuroscience 1999
Diminished G 1 Checkpoint after γ-Irradiation and Altered Cell Cycle Regulation by Insulin-like Growth Factor II Overexpression
L Zhang, M Kim, YH Choi, B Goemans, C Yeung, Z Hu, S Zhan, P Seth, LJ Helman 		The Journal of biological chemistry 1999
IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity
M Menouny, M Binoux, S Babajko 		International Journal of Cancer 1998
Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone
H Wex, P Vorwerk, K Mohnike, D Bretschneider, U Kluba, V Aumann, WF Blum, U Mittler 		British Journal of Cancer 1998
Mononucleotide Repeat Instability Is Infrequent in Neuroblastoma
MD Hogarty, PS White, EP Sulman, GM Brodeur 		Cancer Genetics and Cytogenetics 1998
Studies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells
H Hosoi, MB Dilling, LN Liu, MK Danks, T Shikata, A Sekulic, RT Abraham, JC Lawrence, PJ Houghton 		Molecular pharmacology 1998
Disruption of the MyoD/p21 Pathway in Rhabdomyosarcoma
M Weintraub, T Kalebic, LJ Helman, KG Bhatia 		Sarcoma 1997
Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid
P Lovat, H Irving, M Annicchiaricopetruzzelli, F Bernassola, A Malcolm, A Pearson, G Melino, C Redfern 		European Journal of Cancer 1997
Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: Variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation
W Kiess, G Koepf, H Christiansen, WF Blum 		Regulatory Peptides 1997
Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent Washout
PE Lovat, H Irving, AD Pearson, CP Redfern, AJ Malcolm, M Annicchiarico-Petruzzelli, F Bernassola, G Melino 		JNCI Journal of the National Cancer Institute 1997
Growth Factors and Cytokines in Health and Disease
P Martin, J McCluskey, P Mallucci, S Nodder 		Growth Factors and Cytokines in Health and Disease 1997
Advances in Molecular and Cellular Endocrinology
MR Pollak, EM Brown 		Advances in Molecular and Cellular Endocrinology 1997
Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-β and Retinoic Acid*
M Menouny, M Binoux, S Babajko 		Endocrinology 1997
Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer
JD Evans, MC Eggo, IA Donovan, SR Bramhall, JP Neoptolemos 		International Journal of Gastrointestinal Cancer 1997
Insulin-like growth factors in central nervous system tumors
R P Glick, T Lichtor, T G Unterman 		Journal of Neuro-Oncology 1997
A possible growth factor role of IL-6 in neuroectodermal tumours
E Candi, R A Knight, A Spinedi, P Guerrieri, G Melino 		Journal of Neuro-Oncology 1997
Retinoids and the control of growth/death decisions in human neuroblastoma cell lines
G Melino, C J Thiele, R A Knight, M Piacentini 		Journal of Neuro-Oncology 1997
Developmentally Imprinted Genes as Markers for Bladder Tumor Progression
MJ Cooper, M Fischer, D Komitowski, A Shevelev, E Schulze, I Ariel, ML Tykocinski, S Miron, J Ilan, ND Groot, A Hochberg 		The Journal of Urology 1996
Two Primitive Neuroectodermal Tumor Cell Lines Require an Activated Insulin-like Growth Factor I Receptor for Growth in Vitro
LS Chin, WK Yung, C Raffel 		Neurosurgery 1996
Insulin-like growth factor II in the pathogenesis of human neuroblastoma
KA Sullivan, VP Castle, SM Hanash, EL Feldman 		The American Journal of Pathology 1995
IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood
W Zumkeller, A Mahmood, R Dellow, PN Schofield 		Clinical molecular pathology 1995
IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma
F Hedborg, R Ohlsson, B Sandstedt, L Grimelius, JC Hoehner, S Pählman 		The American Journal of Pathology 1995
Radioimmunoassay of Insulin-like Growth Factors I and II in the Cerebrospinal Fluid of Patients with Pituitary and Other Central Nervous System Tumors:
RP Glick, TG Unterman 		Neurosurgery 1995
Effects of stem cell factor and other bone marrow-derived growth factor on the expression of adhesion molecules and prolifweation of human neuroblastoma cells
D Beckc, N Gross, CB Brognara 		European Journal of Cancer 1995
Differentiation and survival influences of growth factors in human neuroblastoma
S Påhlman, JC Hoehner, E Nånberg, F Hedborg, S Fagerström, C Gestblom, I Johansson, U Larsson, E Lavenius, E Örtoft, H Söderholm 		European Journal of Cancer 1995
Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma
DN Shapiro, BG Jones, LH Shapiro, P Dias, PJ Houghton 		Journal of Clinical Investigation 1994
Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: Autocrine growth stimulation by IGF-II via the IGF-I receptor
K Raile, A H�flich, U Kessler, Y Yang, M Pfuender, WF Blum, H Kolb, HP Schwarz, W Kiess 		Journal of Cellular Physiology 1994
Human colon carcinoma cells ( CaCo-2) synthesize IGF-II and express IGF-I receptors and IGF-II/M6P receptors
A Hoeflich, Y Yang, U Kessler, P Heinz-Erian, H Kolb, W Kiess 		Molecular and Cellular Endocrinology 1994
Multiple levels of control of insulin-like growth factor gene expression
R Zarrilli, CB Bruni, A Riccio 		Molecular and Cellular Endocrinology 1994
Expression and Down-Regulation by Retinoic Acid of IGF Binding Protein-2 and -4 in Medium from Human Neuroblastoma Cells
S Bernardini, S Cianfarani, A Spagnoli, M Annicchiarico-Petruzzelli, G Melino, R Massoud, B Boscherini, A Finazzi-Agró, RG Rosenfeld, G Federici 		Journal of Neuroendocrinology 1994
Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: An immunohistochemical study
A D'Errico, WF Grigioni, M Fiorentino, P Baccarinl, E Lamas, SD Mitri, G Gozzetti, AM Mancini, C Brechot 		Pathology International 1994
Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation
M Frödin, S Gammeltoft 		Proceedings of the National Academy of Sciences 1994
Altered growth and phenotype in clonalmycN transfectants of the sk-n-sh neuroblastoma cell line
N Gross, G Miescher, D Beck, S Favre, C Beretta 		International Journal of Cancer 1994
Atlas of Human Tumor Cell Lines
YC Hung, PG Satyaswaroop, S Tabibzadeh 		Atlas of Human Tumor Cell Lines 1994
Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors
R Tanaka, T Tsushima, H Murakami, K Shizume, T Obara 		World Journal of Surgery 1994
Insulin-like Growth Factors in Central Nervous System Tumors
RP Glick, TG Unterman, L Blaydes, R Hollis 		Annals of the New York Academy of Sciences 1993
Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells
DM Martin, EL Feldman 		Journal of Cellular Physiology 1993
Interferon-γ inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells
DM Martin, RO Carlson, EL Feldman 		Journal of Neuroscience Research 1993
Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma
MA Israel 		Cancer 1993
Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma
TW Burke, S Vuk-Pavlović 		In Vitro Cellular & Developmental Biology - Animal 1993
Structural analysis of the human insulin-like growth factor-II P3 promoter
AM Raizis, MR Eccles, AE Reeve 		Biochemical Journal 1993
Expression of transforming growth factor-beta isoforms in small round cell tumors of childhood. An immunohistochemical study
BK McCune, K Patterson, RS Chandra, S Kapur, MB Sporn, M Tsokos 		The American Journal of Pathology 1993
Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions
K Iihara, H Shiozaki, K Oku, H Tahara, Y Doki, H Oka, T Kadowaki, T Iwazawa, M Inouh, T Mori 		International Journal of Cancer 1993
Effects of serum and insulin-like growth factors on human neuroblastoma cell growth
MA Meghani, DM Martin, JR Singleton, EL Feldman 		Regulatory Peptides 1993
IGF receptor function and regulation in autocrine human neuroblastoma cell growth
DM Martin, JR Singleton, MA Meghani, EL Feldman 		Regulatory Peptides 1993
Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: Retinoic acid may induce IGF-2
G Melino, A Stephanou, M Annicchiarico-Petruzzelli, RA Knight, A Finazzi-Agro, SL Lightman 		Neuroscience Letters 1993
Expression, purification and binding to the receptor of human insulin-like growth factor II
T Miyagishima, S Gasa, K Honke, M Sakai, S Nishi, M Yamamoto, K Nishikawa, T Miyazaki, A Makita 		Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1993
Neurotrophic Factors
DN Ishii 		Neurotrophic Factors 1993
Oncogenes and Tumor Suppressor Genes in Human Malignancies
CC Benz, ET Liu 		1993
Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6
LA Bach, S Hsieh, K Sakano, H Fujiwara, JF Perdue, MM Rechler 		The Journal of biological chemistry 1993
Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma
TW Burke, S Vuk-Pavlović 		In Vitro Cellular & Developmental Biology – Animal 1993
Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival
MJ Cooper, SM Steinberg, J Chatten, AE Evans, MA Israel 		Journal of Clinical Investigation 1992
Insulin and insulin-like growth factors in central nervous system tumors
RP Glick, TG Unterman, MV der Woude, LZ Blaydes 		Journal of Neurosurgery 1992
Insulin-like growth factors and diabetes
LA Bach, MM Rechler 		Diabetes / Metabolism Reviews 1992
Insulin-like growth factors and cancer
VM Macaulay 		British Journal of Cancer 1992
Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha
H Lahm, L Suardet, PL Laurent, JR Fischer, A Ceyhan, JC Givel, N Odartchenko 		British Journal of Cancer 1992
Neuroblastoma in the very young child: biological considerations
JT Kemshead, K Patel, B Phimister 		The British journal of cancer. Supplement 1992
Expression of the B cell-associated tyrosine kinase gene Lyn in primary neuroblastoma tumours and its modulation during the differentiation of neuroblastoma cell lines
W Bielke, A Ziemieki, L Kappos, GC Miescher 		Biochemical and Biophysical Research Communications 1992
Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system
C Nilsson, M Lindvall-Axelsson, C Owman 		Brain Research Reviews 1992
Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines
TG Baier, EW Jenne, W Blum, D Schönberg, KK Hartmann 		Leukemia Research 1992
Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells
A Stephanou, G Melino, RA Knight, M Annicchiarico-Petruzzelli, NJ Sarlis, A Finazzi-Agro', SL Lightman 		Neuropeptides 1992
IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth
G Melino, A Stephanou, M Annicchiaricopetruzzelli, A Finazziagro, R Knight, S Lightman 		Neuroscience Letters 1992
Insulin and insulin-like growth factors in central nervous system tumors: Part V: Production of insulin-like growth factors I and II in vitro
RP Glick, TG Unterman, MV der Woude, LZ Blaydes 		Journal of Neurosurgery 1992
Single umbilical artery ligation-induced fetal growth retardation: effect on postnatal adaptation
K Oyama, J Padbury, B Chappell, A Martinez, H Stein, J Humme 		American journal of physiology. Endocrinology and metabolism 1992
Interleukins and neurohormones: a common language
R Knight, N Sarlis, A Stephanou 		Postgraduate medical journal 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells
CP Minniti, EC Kohn, JH Grubb, WS Sly, Y Oh, HL Müller, RG Rosenfeld, LJ Helman 		The Journal of biological chemistry 1992
Characterisation of a human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones
A Savarese, M Annicchiarico-Petruzzelli, G Citro, G Zupi, LG Spagnoli, A Colantoni, P Vernole, A Stephanou, RA Knight, P Guerrieri, G Melino 		Experimental Brain Research 1992
Insulin-like growth factor II-mediated proliferation of human neuroblastoma
OM El-Badry, LJ Helman, J Chatten, SM Steinberg, AE Evans, MA Israel 		Journal of Clinical Investigation 1991
Biology of tumors of the peripheral nervous system
GM Brodeur, JF Moley 		Cancer and Metastasis Reviews 1991
Autocrine growth factors and solid tumor malignancy
JH Walsh, WE Karnes, F Cuttitta, A Walker 		The Western journal of medicine 1991
Multiple growth factor independence in rat mammary carcinoma cells
SP Ethier, R Moorthy 		Breast Cancer Research and Treatment 1991
Evidence against a role for insulin-like growth factor II in the autonomous growth of rat 18,54-SF cells
P Nissley, L Lee, W Kiess 		Molecular and Cellular Endocrinology 1991
Mannose 6-phosphate potentiates insulin-like growth factor II effects in cultured human neuroblastoma cells
EL Feldman, AE Randolph 		Brain Research 1991
International Review of Cytology
RA Miller 		International Review of Cytology 1991
Insulin-like growth factor-II (IGF-II)/Mannose-6-phosphate receptors are increased in primary human thyroid neoplasms
T Yashiro, T Tsushima, H Murakami, T Obara, Y Fujimoto, K Shizume, K Ito 		European Journal of Cancer and Clinical Oncology 1991
New Insights into the Causes of Cancer
LJ Helman, CJ Thiele 		Pediatric Clinics of North America 1991
Insulin-Like Growth Factor Receptors
P Nissley, W Lopaczynski 		Growth Factors 1991
Tumor Secretion of Growth Factors
WH Daughaday, TF Deuel 		Endocrinology and metabolism clinics of North America 1991
Biology of pediatric peripheral neuroectodermal tumors
CJ Thiele 		Cancer and Metastasis Reviews 1991
Peptide Growth Factors and Their Receptors I
MB Sporn, AB Roberts 		1991
“Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
JR Florini, KA Magri, DZ Ewton, PL James, K Grindstaff, PS Rotwein 		The Journal of biological chemistry 1991
Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor
D Yee, RE Favoni, GS Lebovic, F Lombana, DR Powell, CP Reynolds, N Rosen 		Journal of Clinical Investigation 1990
Insulin-like growth factors I and II
RE HUMBEL 		European Journal of Biochemistry 1990
Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-α
U Rodeck, N Williams, U Murthy, M Herlyn 		Journal of Cellular Biochemistry 1990
EJB Reviews 1990
P Christen, E Hofmann 		1990

Advertisement